Pappas Life Science Ventures Iii L.p. A.m., 10% Owner at CoLucid Pharmaceuticals, Inc. (CLCD), bought 398,757 shares at $10.00 ($3.0M) on 2015-05-11, disclosed to the SEC on 2015-05-12.
Open-market purchase of $3.0M CLCD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 98,757 | $0 | 0.0% |
| 2 | $10.00 | 17,560 | $176K | 5.9% |
| 3 | $10.00 | 282,440 | $2.8M | 94.1% |
| Total | $7.52 avg | 398,757 | $3.0M | 100% |